isolated to date, and they were classified into three cate-
gories A1ꢀ7, B1ꢀ7, and C1ꢀ5 according to the oxygenation
pattern; their structures were initially assigned on the
basis of NMR analysis.1 They are inhibitors of R- and
β-glucosidases, β-galactosidases, amyloglucosidases, and
R-L-fucosidases1 and may have chemotherapeutic poten-
tial in the treatment of diabetes II, cancer, and viral
infections.2 Consequently, many efforts for devising gen-
eral strategies for accessing them and their congeners have
been prompted.
The majority of these synthetic methods start with a
chiral pool which have the identical stereocenters to the
alkaloid.3 Meanwhile, de novo approaches, which include
chemoenzymatic procedures utilizinganadolase,4 versatile
routes reliant on the enzymatic desymmetrization of
dihydropyrrole,5 and syntheses through the use of diaster-
eoselective dichloroketeneꢀchiral enol ether cycloaddi-
tion,6 making the hyacinthacines more available.
methods for this class of compound would allow evaluation
of their potential biological activities. Our retrosynthetic
strategy of hyacinthacine C5 is depicted in Scheme 1. Starting
from the cyclic nitrone 59 with three chiral centers, the stereo
center of C7a could be established via diastereoselective
addition of lithio-dithiane 6. The hydroxyl group at C7 could
be derived from dethioketalization and diastereoselective
reduction; the hydroxyl group at C6 could be initially
installed at the dithiane side chain. The chiral center at C5
was commonly introduced by intramolecular SN2 substitu-
tion3m,h or reductive amination3f,i,k or Bruylants alkyla-
tion,6b,9g but all these methods involved cumbersome steps.
Kaliappan’s method10 employing CopeꢀHouse cyclization11
gave excellent diastereoselectivity, and the stereochemical
pattern was identical with that of (ꢀ)-hyacinthacine C5.
Scheme 1. Retrosynthetic Analysis of (ꢀ)-Hyacinthacine C5
Ten hyacinthacines (A1ꢀA3, A5ꢀA7, B1ꢀB3, C2) have
3m
been synthesized and their absolute configurations as-
signed. Unambiguous syntheses of hyacinthacine B7
and C33h have shown that the initially proposed structures
were incorrect; the 1H and 13C NMR spectral data of the
synthetic and isolated compounds were not consistent.
There are no reports of the synthesis of hyacinthacines
7
C1, C4 and C5 with substituents at each carbon of the
pyrrolizidine nucleus so that their absolute configurations
have yet to be determined; only a few analogues have been
synthesized.8 This series of pyrrolizidines has four hydro-
xyl groups, one hydroxymethyl group and one methyl
group attached to each of the seven adjacent chiral centers
(Figure 1).
Since cyclic nitrone 5 could be easily prepared on a large
scale according to our improved approach,9c we investi-
gated the addition of 2-lithio-1, 3-dithiane derivatives to
nitrone 5. As a classical umpolung synthon, dithiane has
been widely applied in reversing the reactivity of carbonyl
groups.12 Although additions of 2-lithio-1,3-dithiane
(9) For the synthesis of nitrone 5, see: (a) Gurjar, M. K.; Borhade,
R. G.; Puranik, V. G.; Ramana, C. V. Tetrahedron Lett. 2006, 47, 6979.
(b) Yu, C. Y.; Huang, M. H. Org. Lett. 2006, 8, 3021. (c) Wang, W. B.;
Huang, M. H.; Li, Y. X.; Rui, P. X.; Hu, X. G.; Zhang, W.; Su, J. K.;
Zhang, Z. L.; Zhu, J. S.; Xu, W. H.; Xie, X. Q.; Jia, Y. M.; Yu, C. Y.
Synlett 2010, 488. For the application of cyclic nitrone, see:(d) Tsou,
E. L.; Chen, S. Y.; Yang, M. H.; Wang, S. C.; Cheng, T. R. R.; Cheng,
W. C. Bioorg. Med. Chem. 2008, 16, 10198. (e) Tsou, E. L.; Yeh, Y. T.;
Liang, P. H.; Cheng, W. C. Tetrahedron 2009, 65, 93. (f) Su, J. K.; Jia,
Y. M.; He, R. R.; Rui, P. X.; Han, N. Y.; He, X. H.; Xiang, J. F.; Chen,
X.; Zhu, J. H.; Yu, C. Y. Synlett 2010, 1609. (g) Hu, X. G.; Jia, Y. M.;
Xiang, J. F.; Yu, C. Y. Synlett 2010, 982. For recent reviews of cyclic
nitrone, see:(h) Revuelta, J.; Cicchi, S.; Goti, A.; Brandi, A. Synthesis
2007, 485. (i) Brandi, A.; Cardona, F.; Cicchi, S.; Cordero, F. M.; Goti,
A. Chem.;Eur. J. 2009, 15, 7808.
Figure 1. Examples of fully substituted pyrrolizidines.
These enticing structures pose a great challenge for their
total syntheses. The development of general synthetic
(10) Kaliappan, K. P.; Das, P. Synlett 2008, 841.
(11) For recent reviews, see: (a) Cooper, N. J.; Knight, D. W.
Tetrahedron 2004, 60, 243. (b) Bainbridge, N. P.; Currie, A. C.; Cooper,
N. J.; Muir, J. C.; Knight, D. W.; Walton, J. M. Tetrahedron Lett. 2007,
48, 7782. For application in iminosugar syntheses, see: (c) Palmer,
A. M.; Jager, V. Eur. J. Org. Chem. 2001, 2547. (d) Palmer, A. M.; Jager,
V. Eur. J. Org. Chem. 2001, 1293. (e) Palmer, A. M.; Jager, V. Synlett
2000, 1405. (f) Jager, V.; Bierer, L.; Dong, H. Q.; Palmer, A. M.; Shaw,
D.; Frey, W. J. Heterocycl. Chem. 2000, 37, 455.
(12) Smith, A. B.; Adams, C. M. Acc. Chem. Res. 2004, 37, 365.
(13) (a) Furneaux, R. H.; Schramm, V. L.; Tyler, P. C. Bioorg. Med.
Chem. 1999, 7, 2599. (b) Davis, F. A.; Ramachandar, T.; Liu, H. Org.
Lett. 2004, 6, 3393. (c) Xu, X.; Liu, J. Y.; Chen, D. J.; Timmons, C.; Li,
G. G. Eur. J. Org. Chem. 2005, 1805.
(4) Calveras, J.; Casas, J.; Parella, T.; Joglar, J.; Clapes, P. Adv.
Synth. Catal. 2007, 349, 1661.
(5) Donohoe, T. J.; Thomas, R. E.; Cheeseman, M. D.; Rigby, C. L.;
Bhalay, G.; Linney, I. D. Org. Lett. 2008, 10, 3615.
(6) (a) Reddy, P. V.; Veyron, A.; Koos, P.; Bayle, A.; Greene, A. E.;
Delair, P. Org. Biomol. Chem. 2008, 6, 1170. (b) Reddy, P. V.; Koos, P.;
Veyron, A.; Greene, A. E.; Delair, P. Synlett. 2009, 1141.
(7) Hyacinthacine C4 has been determined to be the same structure as
hyacinthacine C1 (see ref 1d).
ꢀ
(8) (a) Tamayo, J. A.; Franco, F.; Sanchez-Cantalejo, F. Tetrahedron
2010, 66, 7262. (b) Yu, C.; Gao, H. CN200610113357, 2006.
Org. Lett., Vol. 13, No. 16, 2011
4415